Reaction
Glycosylated Haemoglobin Decreased reporting signals
As of the last recalculation, Glycosylated Haemoglobin Decreased appears in 1,573 FAERS reports alongside 30 co-occurring drug terms. The strongest observed disproportionality signal is ORAL SEMAGLUTIDE (PRR 29.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Oral Semaglutide | 149 | 29.6 | 29.6 |
| Empagliflozin | 129 | 27.5 | 27.6 |
| Liraglutide | 71 | 19.9 | 19.9 |
| Dulaglutide | 122 | 19.7 | 19.7 |
| Insulin Glulisine | 13 | 17.0 | 17.1 |
| Canagliflozin | 37 | 16.7 | 16.8 |
| Insulin Human | 40 | 13.6 | 13.6 |
| Glimepiride | 39 | 13.6 | 13.6 |
| Linagliptin | 18 | 13.2 | 13.2 |
| Sitagliptin | 66 | 12.6 | 12.6 |
| Insulin Glargine | 193 | 11.7 | 11.7 |
| Sacubitril And Valsartan | 95 | 11.5 | 11.5 |
| Metformin Er 500 Mg | 223 | 11.3 | 11.3 |
| Metformin Er 750 Mg | 223 | 11.3 | 11.3 |
| Sitagliptin And Metformin Hydrochloride | 18 | 11.2 | 11.2 |
| Glipizide | 47 | 10.5 | 10.5 |
| Metformin | 243 | 10.5 | 10.5 |
| Insulin Degludec | 18 | 10.3 | 10.3 |
| Insulin Aspart | 49 | 10.1 | 10.1 |
| Exenatide | 39 | 10.0 | 10.0 |
| Insulin Lispro | 91 | 9.2 | 9.2 |
| Human Insulin | 8 | 8.5 | 8.5 |
| Lanreotide Acetate | 4 | 6.8 | 6.8 |
| Faricimab | 4 | 6.5 | 6.5 |
| Metformin Hcl | 26 | 6.3 | 6.3 |
| Tirzepatide | 73 | 6.2 | 6.2 |
| Sofosbuvir | 6 | 4.0 | 4.0 |
| Evolocumab | 32 | 2.6 | 2.6 |
| Alirocumab | 5 | 2.6 | 2.6 |
| Relugolix | 4 | 2.2 | 2.2 |